COVID-19 and Cancer: Biological Interconnection and Treatment

Nidhi Jyotsana

A chapter in Biotechnology to Combat COVID-19 from IntechOpen

Abstract: The COVID-19 pandemic has affected more than 125 million lives worldwide and more than 2.5 million people have died so far. Cancer in itself increases the risk of infection especially, cancer patients undergoing cancer-associated treatments are more susceptible to SARS-CoV2 infection. However, many questions related to the biological interconnection between the two diseases remain to be answered. This chapter summarizes some of the biological components that connect cancer to COVID-19 and provide knowledge to not only understand but also, target the co-morbidities.

Keywords: COVID-19; cancer; viral infections; chemotherapy; radiotherapy; immunotherapy; cytokine storm; coagulopathy; ACE2; TMPRSS2 (search for similar items in EconPapers)
JEL-codes: I18 (search for similar items in EconPapers)
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.intechopen.com/chapters/76409 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ito:pchaps:231867

DOI: 10.5772/intechopen.97482

Access Statistics for this chapter

More chapters in Chapters from IntechOpen
Bibliographic data for series maintained by Slobodan Momcilovic ().